Respirology Volume 25, Issue 8 Pages: 771-904 August 2020
|
ISSUE INFORMATION
Pages: 771-775 | First Published: 15 July 2020
Cover image: Asthma/COPD overlap (ACO) is a diagnostic label which attempts to consider the overlapping clinical features of each condition. However, numerous definitions and unclear treatment limits its clinical value. (Illustration credit: Dr Ciléin Kearns) See Kearns et al on p781-783 and Barrecheguren et al., p836-849.
EDITORIALS
Pages: 776-778 | First Published: 23 June 2020
See related article
Pages: 779-780 | First Published: 08 March 2020
See related article
Pages: 781-783 | First Published: 31 March 2020
Pages: 784-786 | First Published: 05 December 2019
See related article
Pages: 787-789 | First Published: 16 April 2020
See related article
Pages: 790-792 | First Published: 01 April 2020
See related article
Pages: 793-794 | First Published: 08 March 2020
See related article
COMMENTARIES
Pages: 795-796 | First Published: 30 March 2020
Pages: 797-799 | First Published: 17 June 2020
Pages: 800-801 | First Published: 01 July 2020
Pages: 802-803 | First Published: 12 June 2020
INVITED REVIEWS
Pages: 804-815 | First Published: 31 March 2020
See related Editorial
Pages: 816-826 | First Published: 03 May 2020
ORIGINAL ARTICLES
Asthma and Allergy
Pages: 827-835 | First Published: 05 February 2020
In the present study, we found that baseline measures of small airway function by forced oscillation technique (FOT) and multiple‐breath nitrogen washout (MBNW) predicted improved asthma control upon inhaled corticosteroid (ICS) up‐titration, suggesting that FOT and MBNW may provide important markers for assessing ICS responsiveness.
See related Editorial
COPD
Pages: 836-849 | First Published: 16 February 2020
Lack of consensus on the diagnosis of ACO limits our understanding of impact and outcomes. We identified individuals with ACO in the CanCOLD population by using seven clinical definitions. Asthma and atopy were the features that best identified ACO, and these patients had worse outcomes.
See related Editorial
See cover image
Interstitial Lung Disease
Pages: 850-854 | First Published: 06 November 2019
Patients with NSCLC and ILD did not have high TMB and could develop severe pneumonitis if immune checkpoint inhibitors are used. Therefore, immune checkpoint inhibitors should not be used based on expectations of high TMB in patients with NSCLC and ILD.
See related Editorial
Pages: 855-862 | First Published: 17 February 2020
To better understand the natural variation of HAA (a novel quantitative CT‐based measure of subclinical ILD), we developed HAA reference equations and z‐scores to define expected values of HAA with adjustment for key demographic and anthropometric variables, and we demonstrated that HAA z‐scores correlate with several ILD features.
See related Editorial
Pulmonary Vascular Disease
Pages: 863-871 | First Published: 30 January 2020
We examined diagnostic delay in a large binational cohort of PAH patients. Mean and median diagnostic intervals were 2.5+/–4.1 and 1.2 (IQR: 0.6–2.7) years, respectively. Age, cardiovascular and respiratory comorbidities were associated with longer diagnostic interval. Mortality was increased in patients with greater diagnostic interval.
See related Editorial
Sleep and Ventilation
Pages: 872-879 | First Published: 24 December 2019
The link between PLMS and cardiovascular alterations is still debated. Our current study aimed to address the effects of PLMS on BP in a large unselected OSA patient cohort, showing that the PLMS phenotype is associated with significantly elevated clinical SBP independent of confounders.
See related Editorial
20 of 31 articles shown
View all articlesYou are receiving this content alert because you are subscribed to Respirology .
If you no longer wish to receive these alerts you can unsubscribe here.
You can manage all of your Wiley Online Library content alerts at https://onlinelibrary.wiley.com.